Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490

Journal of Inflammation

Volumn 6, Issue , 2009, Pages

  Dimitrova, Petya ^a   Gyurkovska, Valeriya ^a   Shalova, Irina ^b   Saso, Luciano ^c   Ivanovska, Nina ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; RANTES; STAT1 PROTEIN; STAT3 PROTEIN; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GLOMERULUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; MOUSE; NEPHRITIS; NONHUMAN; PERITONEUM CELL; PERITONEUM LAVAGE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEINURIA; SHOCK; SURVIVAL RATE;

MUS;

EID: 66649138242     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-6-13     Document Type: Article

References (56)

1. Acute renal failure. N Lameire W Van Biesen R Vanholder, Lancet 2005 365 417 430 15680458 (Pubitemid 40179230)
2. Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome. AB Groeneveld DD Tran J van der Meulen JJ Nauta LG Thijs, Nephron 1991 59 602 610 10.1159/000186651 1766500
3. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. EA Hoste NH Lameire RC Vanholder DD Benoit JM Decruyenaere FA Colardyn, J Am Soc Nephrol 2003 14 1022 1030 10.1097/01.ASN.0000059863.48590.E9 12660337
4. Pro-inflammatory cytokines and interleukin 6 in the renal response to bacterial endotoxin. F Kayama T Yoshida Y Kodama T Matsui JM Matheson MI Luster, Cytokine 1997 9 688 695 10.1006/cyto.1997.0214 9325018
5. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. W Mu X Ouyang A Agarwal L Zhang DA Long PE Cruz CA Roncal OY Glushakova VA Chiodo MA Atkinson, J Am Soc Nephrol 2005 16 3651 3660 10.1681/ASN.2005030297 16251240
6. Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. TJ Volman T Hendriks RJ Goris, Shock 2005 23 291 297 10.1097/01.shk.0000155350.95435.28 15803050
7. Tissue- and time-dependent upregulation of cytokine mRNA in a murine model for the multiple organ dysfunction syndrome. TJ Volman RJ Goris JW van der Meer T Hendriks, Ann Surg 2004 240 142 150 15213630 10.1097/01.sla.0000130725. 52373.e7
8. Gradual development of organ damage in the murine zymosan-induced multiple organ dysfunction syndrome. MJ Jansen T Hendriks AA Verhofstad W Lange LM Geeraedts Jr RJ Goris, Shock 1997 8 261 267 10.1097/00024382-199710000-00005 9329127 (Pubitemid 127654336)
9. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A. M Sato H Sano D Iwaki K Kudo M Konishi H Takahashi T Takahashi H Imaizumi Y Asai Y Kuroki, J Immunol 2003 171 417 425 12817025 (Pubitemid 36745315)
10. Macrophage recognition of zymosan particles. DM Underhill, J Endotoxin Res 2003 9 176 180 12831459 (Pubitemid 36722597)
11. Dectin-1 mediates the biological effects of beta-glucans. GD Brown J Herre DL Williams JA Willment AS Marshall S Gordon, J Exp Med 2003 197 1119 1124 12719478 10.1084/jem.20021890
12. Activation of the alternative complement pathway due to resistance of zymosan-bound. DT Fearon KF Austen, Proc Natl Acad Sci USA 1977 74 1683 1687 266208 10.1073/pnas.74.4.1683
13. Properdin deficiency in murine models of nonseptic shock. ND Ivanovska PA Dimitrova JC Luckett R El-Rachkidy Lonnen WJ Schwaeble CM Stover, J Immunol 2008 180 6962 6969 18453618
14. Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function. T Goya T Morisaki M Torisu, Surgery 1994 115 145 155 8310402 (Pubitemid 24057482)
15. Complement and the kidney. RJ Quigg, J Immunol 2003 171 3319 3324 14500622 (Pubitemid 37254529)
16. Function, structure and therapeutic potential of complement C5a receptors. PN Monk AM Scola P Madala DP Fairlie, Br J Pharmacol 2007 152 429 448 17603557 10.1038/sj.bjp.0707332
17. Tyrphostin AG490, a tyrosine kinase inhibitor, blocks actively induced experimental autoimmune encephalomyelitis. G Constantin S Brocke A Izikson C Laudanna EC Butcher, Eur J Immunol 1998 28 3523 3529 9842895 10.1002/(SICI)1521-4141(199811)28:11<3523::AID-IMMU3523>3.0.CO;2-X (Pubitemid 28510763)
18. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. V Gouilleux-Gruart F Gouilleux C Desaint JF Claisse JC Capiod J Delobel R Weber-Nordt I Dusanter-Fourt F Dreyfus B Groner L Prin, Blood 1996 87 1692 1697 8634413 (Pubitemid 26068885)
19. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Q Zhang I Nowak EC Vonderheid AH Rook ME Kadin PC Nowell LM Shaw MA Wasik, Proc Natl Acad Sci USA 1996 93 9148 9153 8799169 10.1073/pnas.93.17.9148
20. Role of Janus kinase/signal transducer and activator of transcription pathway in regulation of expression and inflammation-promoting activity of high mobility group box protein 1 in rat peritoneal macrophages. H Liu YM Yao Y Yu N Dong HN Yin ZY Sheng, Shock 2007 27 55 60 10.1097/01.shk.0000233197.40989.31 17172981
21. JAK inhibitors AG-490 and WHI-P154 decrease IFN-gamma-induced iNOS expression and NO production in macrophages. O Sareila R Korhonen O Karpanniemi R Nieminen H Kankaanranta E Moilanen, Mediators Inflamm 2006 2006 16161 16883061 10.1155/MI/2006/16161
22. Inhibition of Jak/STAT signaling ameliorates mice experimental nephrotic syndrome. R Li N Yang L Zhang Y Huang R Zhang F Wang M Luo Y Liang X Yu, Am J Nephrol 2007 27 580 589 10.1159/000108102 17823504
23. Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat. N Yang M Luo R Li Y Huang R Zhang Q Wu F Wang Y Li X Yu, Nephrol Dial Transplant 2008 23 91 100 10.1093/ndt/gfm509 17670769
24. Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA. P Dimitrova M Yordanov S Danova N Ivanovska, FEMS Immunol Med Microbiol 2008 53 231 236 10.1111/j.1574-695X.2008.00421.x 18507679
25. Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation. P Dimitrova N Ivanovska, Int Immunopharmacol 2008 8 1567 1577 10.1016/j.intimp.2008.06.013 18656556
26. Etoposide attenuates zymosan-induced shock in mice. M Remichkova M Yordanov P Dimitrova, Inflammation 2008 31 57 64 10.1007/s10753-007-9049-8 17924177
27. TLR2 modulates inflammation in zymosan-induced arthritis in mice. ME Frasnelli D Tarussio V Chobaz-Peclat N Busso A So, Arthritis Res Ther 2005 7 R370 379 15743485 10.1186/ar1494
28. Changes of immunoreactivity in alpha 1-antitrypsin in patients with autoimmune diseases. L Saso B Silvestrini R Lahita CY Cheng, Inflammation 1993 17 383 400 10.1007/BF00918999 7687239
29. Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro. AF Popi JD Lopes M Mariano, Immunology 2004 113 348 354 15500621 10.1111/j.1365-2567.2004.01969.x
30. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. MN Ajuebor AM Das L Virag RJ Flower C Szabo M Perretti, J Immunol 1999 162 1685 1691 9973430 (Pubitemid 29307046)
31. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. X Zhang Y Kimura C Fang L Zhou G Sfyroera JD Lambris RA Wetsel T Miwa WC Song, Blood 2007 110 228 236 17363730 10.1182/blood-2006-12- 063636
32. Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. IJ Laudes JC Chu S Sikranth M Huber-Lang RF Guo N Riedemann JV Sarma AH Schmaier PA Ward, Am J Pathol 2002 160 1867 1875 12000738 (Pubitemid 34525666)
33. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. JC Marshall, Crit Care Med 2001 29 S99 106 10.1097/00003246-200107001-00032 11445742
34. STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells. I Arany JK Megyesi BD Nelkin RL Safirstein, Kidney Int 2006 70 669 674 10.1038/sj.ki.5001604 16788692
35. Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. M Yanagita H Arai T Nakano K Ohashi K Mizuno A Fukatsu T Doi T Kita, J Biol Chem 2001 276 42364 42369 10.1074/jbc.M107488200 11546821
36. Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice. J Dong QX Wang CY Zhou XF Ma YC Zhang, Lupus 2007 16 101 109 10.1177/0961203306075383 17402366
37. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. N Yokota M Burne-Taney L Racusen H Rabb, Am J Physiol Renal Physiol 2003 285 F319 325 12709397
38. IL-6/IL-6R axis plays a critical role in acute kidney injury. Y Nechemia-Arbely D Barkan G Pizov A Shriki S Rose-John E Galun JH Axelrod, J Am Soc Nephrol 2008 19 1106 1115 10.1681/ASN.2007070744 18337485
39. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. X Hu J Chen L Wang LB Ivashkiv, J Leukoc Biol 2007 82 237 243 10.1189/jlb.1206763 17502339
40. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. X Hu PK Paik J Chen A Yarilina L Kockeritz TT Lu JR Woodgett LB Ivashkiv, Immunity 2006 24 563 574 10.1016/j.immuni.2006.02.014 16713974
41. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. AA Shigeoka TD Holscher AJ King FW Hall WB Kiosses PS Tobias N Mackman DB McKay, J Immunol 2007 178 6252 6258 17475853 (Pubitemid 46717408)
42. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. A Kaufmann R Salentin D Gemsa H Sprenger, J Leukoc Biol 2001 69 248 252 11272275 (Pubitemid 32163437)
43. Macrophages and the kidney. HM Wilson D Walbaum AJ Rees, Curr Opin Nephrol Hypertens 2004 13 285 290 10.1097/00041552-200405000-00004 15073486
44. Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. DB Ascon S Lopez-Briones M Liu M Ascon V Savransky RB Colvin MJ Soloski H Rabb, J Immunol 2006 177 3380 3387 16920979 (Pubitemid 44277858)
45. T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. RK Phoon AR Kitching D Odobasic LK Jones TJ Semple SR Holdsworth, J Am Soc Nephrol 2008 19 477 485 18235099 10.1681/ASN.2007030392
46. B cell deficiency confers protection from renal ischemia reperfusion injury. MJ Burne-Taney DB Ascon F Daniels L Racusen W Baldwin H Rabb, J Immunol 2003 171 3210 3215 12960350 (Pubitemid 37093547)
47. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. MJ Burne F Daniels A El Ghandour S Mauiyyedi RB Colvin MP O'Donnell H Rabb, J Clin Invest 2001 108 1283 1290 11696572 (Pubitemid 33107755)
48. A key role of C5a/C5aR activation for the development of sepsis. NC Riedemann RF Guo PA Ward, J Leukoc Biol 2003 74 966 970 10.1189/jlb.0403137 12960283
49. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. DL Haviland RL McCoy WT Whitehead H Akama EP Molmenti A Brown JC Haviland WC Parks DH Perlmutter RA Wetsel, J Immunol 1995 154 1861 1869 7836770
50. C5a receptor and thymocyte apoptosis in sepsis. NC Riedemann RF Guo IJ Laudes K Keller VJ Sarma V Padgaonkar FS Zetoune PA Ward, Faseb J 2002 16 887 888 12039868
51. Neutrophil C5a receptor and the outcome in a rat model of sepsis. RF Guo NC Riedemann KD Bernacki VJ Sarma IJ Laudes JS Reuben EM Younkin TA Neff JD Paulauskis FS Zetoune PA Ward, Faseb J 2003 17 1889 1891 12897064
52. Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation. J Skokowa SR Ali O Felda V Kumar S Konrad N Shushakova RE Schmidt RP Piekorz B Nurnberg K Spicher, J Immunol 2005 174 3041 3050 15728518 (Pubitemid 40279725)
53. Physiological and pathological aspects of circulating immune complexes. JA Schifferli RP Taylor, Kidney Int 1989 35 993 1003 10.1038/ki.1989.83 2651776 (Pubitemid 19099713)
54. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. SH Nasr GS Markowitz MB Stokes SV Seshan E Valderrama GB Appel P Aucouturier VD D'Agati, Kidney Int 2004 65 85 96 10.1111/j.1523-1755.2004.00365.x 14675039
55. Extravasations and emigration of neutrophils to the inflammatory site depend on the interaction of immune-complex with Fcgamma receptors and can be effectively blocked by decoy Fcgamma receptors. R Shashidharamurthy RA Hennigar S Fuchs P Palaniswami M Sherman P Selvaraj, Blood 2008 111 894 904 17962513 10.1182/blood-2007-04-085944
56. Epitope spreading in immune-mediated diseases: implications for immunotherapy. CL Vanderlugt SD Miller, Nat Rev Immunol 2002 2 85 95 10.1038/nri724 11910899 (Pubitemid 37323232)